Efficient control of leukaemia with treatment ... - CLL Support
Efficient control of leukaemia with treatment by dual immune-checkpoint blockade
Written by
Medabouhedi
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Alterations of the immune system caused by CLL B‐cells
Abstract: Here, we review the current understanding of the underlying interplay between the...
BBC News - 18/04 - Breakthrough in leukaemia treatment (Prof Chris Pepper of Cardiff University on Ibrutinib)
Scientists helped to develop drugs which target the disease at a molecular level
By Carwyn Jones...
Phase I/II trial of IPH2201 checkpoint inhibitor in combination with ibrutinib opens for patients with relapsed or refractory CLL
"This Phase Ib/IIa study is a multicenter open label trial of the combination of IPH2201 and...
Role of RITUXIMAB in CLL treatment in combination with Venetoclax
Hello to all fellows in the CLL journey!
Has anyone found a clear answer as to what exactly is the...
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
Key points:
1. The immunosuppressive footprint of CLL on nonmalignant lymphocytes is more...
Related Posts
Doc says it's usual to start treatment with doubling of WCC- Avoiding COVID-19 Infection when you have Chronic Lymphocytic Leukaemia or SLL, by Chaya Venkat of CLL Topics/Updates (speculative article)
- Opportunity to support the listing of Acalabrutinib and Venetoclax for the treatment of Australians with CLL
- Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL
Treatment of My Father suffering from CLL with Endoxan (Cyclophosphamide) and Bendit--Bendamustine Hydrochloride.
